Acessibilidade / Reportar erro

The transfusion medicine we want

FORUM

The transfusion medicine we want

Correspondence Correspondence: Associação Brasileira de Hematologia e Hemoterapia Rua da Assembléia, 10 Gr. 1407 - Centro Rio de Janeiro (RJ), Brazil

ABSTRACT

The Associação Brasileira de Hematologia e Hemoterapia (ABHH), through its Board of Directors, hosted a national symposium called "Forum: The Transfusion Medicine we want", to discuss proposed policies and techniques related to the area. This meeting was held in São Paulo on August 19 and 20, 2010, with the participation of experts, authorities and representatives of organized groups of patients and users.

The discussions were organized around three specific issues selected from over 100 suggestions sent to the ABHH through public consultation on the web: 1. Strategies; 2. Financing; 3. Blood products.

A plenary session, held at the end of the meeting, adopted recommendations that are relevant to the different discussion topics.

This document contains actions proposed by the ABHH to meet the demands discussed.

Forum proposals

Compilation of the proposals to draft the final document of the ABHH.

Strategies

1. That the ABHH should have seats on state and national technical committees.

2. That patient care outside the government healthcare plan in both public and private settings should be paid for according to the Brazilian Hierarchy Classification of Medical Procedures (CBHPM).

3. The structuring of educational programs in blood centers, the ABHH and in governmental agencies (funding for courses, scholarships, etc.) should be stimulated with the aim of qualifying professionals who work with transfusion therapy.

4. That a minimum curriculum for transfusion medicine should be proposed for Medicine Schools and for other healthcare courses at undergraduate and postgraduate levels. The transfusion committee should be consulted as a source in transfusion therapy education.

5. The residency in Hematology and transfusion medicine should be for a minimum of three years with one year devoted solely to transfusion medicine.

6. The title of specialist in hematology / transfusion medicine should be valorized (salary, valorize the professional, etc.).

7. The remuneration of transfusion procedures that are developed in transfusion agencies should be reviewed to guarantee improvements in transfusion procedures and in the pay of doctors active in transfusion services.

8. A quality certification program for transfusion services accredited by the American Association of Blood Banks - AABB/ABHH should be implemented.

9. "Standards" of ABHH similar to the AABB should be created.

10. There should be stimulation to offer internships to all professionals working in transfusion medicine (public and private).

11. That the coordinator of the Hematology and Transfusion Medicine Technical Committee at Regional and National Medicine Councils (CRM) should be indicated (with a substitute) by the ABHH.

12. That the ABHH should sponsor discussions with ANVISA and the General Coordination of Blood and Blood Products (CGSH) in order to stimulate the creation of a technical support structure for transfusion medicine in Hemorrede.

13. Specific forums should be organized on health safety.

14. The ABHH should suggest, through its scientific committee, issues of relevance to the country that should be publicized in newsletters, instigating discussions aimed at the inclusion of procedures to improve transfusion safety (NAT - nucleic acid testing, Microbiological study of platelet concentrates, etc.).

15. The ABHH must act together with the Ministry of Health for the transfusion committee to work in the contracting of the hospital services.

16. Transfusion committee members should be professionalized similar to members of the Control of Hospital Infection Committees (CCIH).

17. The ABHH should assess the qualifications of those responsible for transfusion services and when considered unqualified, they should be trained by the ABHH together with Health Surveillance Institutions (VISAs), so that the minimum standard is achieved for them to perform their duties.

18. The ABHH should sponsor a forum specifically to discuss possible business models for blood centers.

Financing

1. It was proposed that the ABHH should participate with the CGSH in negotiations with the Ministry of Health on increases in funding and financing for transfusion medicine services.

2. The ABHH with the National Supplementary Health Agency (ANS) should discuss with the Confederation of Unimeds and equivalent organizations to clarify procedures that should be performed, and therefore paid for, to transfusion services.

3. A working group should be set up by the ABHH to propose replacing the 1737/04 and 1469/06 federal rulings with new guidelines to pay for blood products provided to the private sector based on the CBHPM table.

4. New procedures should be permanently included in the government healthcare and private sector pricelists.

5. A permanent technical commission should be created in the ABHH to meet demands on remuneration, updating pricelists, etc..

6. Nucleic acid testing to screen blood donors should be mandatory immediately.

7. Care provided by transfusion services should be complete, including everything that is part of the specialty as listed in the contract.

8. The ABHH should have greater participation in evaluations and alterations of the values and procedures on the CBHPM pricelist.

9. The ABHH should recommend adoption of the CBHPM pricelist and reductions in price of more than 20% should be considered demeaning and unethical.

10. The ABHH should manifest in respect to medical and non-medical societies that are involved in transfusion medicine procedures without scientific evidence, except for clinical research after it has been duly approved by Research Ethics Committees. The ABHH should regulate the implementation of scientifically-proven proceedings by requiring the active participation of a hematologist specialist in transfusion medicine.

11. Cell Therapy should be incorporation as a transfusion therapy procedure.

Blood products

1. The rational use of plasma was proposed, suggesting that common plasma should be used by the Butantan Institute (immunoglobulin and albumin) and fresh frozen plasma by Hemobrás.

2. The ABHH and the Brazilian Federation of Hemophilia (FBH) should request a description of the technological processes used by producers.

3. It was proposed that factories should present economic-financial viability studies.

4. It was proposed that the investment in research and development of recombinant drug production should be increased.

5. It was suggested that the ABHH should formally demonstrate their concern about the possibility that biological medicines are considered bio-similar or biogenerics in favor of the requirement of clinical trials to be registered in ANVISA.

6. It was suggested that the ABHH should formally demonstrate regarding the purchase of medicines by the Ministry of Health, so that high quality products are always purchased.

7. It was proposed that immunoglobulin should be produced as a liquid, ready to use, without sugar or sodium and preferably at a concentration of 10%.

8. It was proposed that blood transfusion therapy should again be the priority, including in respect to government resources.

9. It was proposed that all procedures related to hematology and transfusion medicine, including cell therapy and bone marrow transplantation, should, in future, be coordinated by one team in the Ministry of Health as with the coordination of blood services.

10. It was proposed that cell therapy should be incorporated within the scope of the ABHH and even include 'cell therapy' in the name of the association.

11. It was recommended that access to bone marrow transplant should be guaranteed for patients with primary immunodeficiency

Actions proposed by ABHH

1. ABHH will send a document to the Ministry of Health and State Health Departments, stating that the ABHH represents the specialty in Hematology and Transfusion Medicine in the country and, as such, requests representation on Medical Specialties Advisory Committees.

2. The ABHH will defend the use of the CBHPM pricelist as the only reference for remuneration of hematology and transfusion medicine services carried out for patients outside the government healthcare system by both government and private institutions.

3. The ABHH will participate to develop educational programs to guarantee the minimum required qualifications in undergraduate, postgraduate and professional courses for physicians and other professionals working in the specialty.

4. The ABHH will create training programs to qualify non-specialist physicians to act as technically responsible for transfusion agencies.

5. The ABHH will send a document to transfusion services reinforcing the need of a specialist title in transfusion medicine for all physicians working in the service.

6. The ABHH will review the minimum criteria to obtain the title of specialist in hematology and transfusion medicine.

7. The ABHH is currently in the process of developing and implementing a quality certification program jointly with the AABB.

8. The ABHH proposed to the AABB to translate the "standards" of the AABB, with appropriate adaptations to the needs of Brazil.

9. The ABHH will request that hematology and transfusion medicine coordinators on technical commissions of Federal and Regional Medical Councils and their substitutes are indicated by the ABHH itself.

10. The ABHH will request that the National Agency for Sanitary Surveillance (ANVISA) and General Coordination of Blood and Blood Products (CGSH) participate in discussions in respect to technical matters and policies, including the incorporation of new technologies and procedures in the scope of the ABHH.

11. The ABHH will increase its participation in the Brazilian Medical Association (AMA) to defend the professional interests of the specialty in national health agencies, healthcare plans and medical cooperatives.

12. The ABHH will standardize scientifically-proven procedures which are regarded as the exclusive realm of transfusion medicine (e.g. the use of platelet rich plasma (PRP) for purposes not related to transfusions) and request that these norms are incorporated into the technical standards used by health surveillance institutions during inspections of medical facilities.

13. The ABHH considers nucleic acid amplification technique (NAT) for blood-borne infectious agents should be obligatory. Thus the ABHH has accepted the responsibility together with a representative of state public prosecutor office (Sao Paulo) to draft a technical paper on security issues related to NAT assays, which will be forwarded to federal public prosecutors, to propose measures to establish a legal requirement to immediately perform these tests and to define remuneration.

14. The ABHH believes tests to detect bacterial contamination in units of platelet concentrates must be mandatory.

15. The ABHH believes that remuneration of transfusion therapy must reflect the complexity, responsibility and costs involved or risk prejudicing the quality. The ABHH believes that remuneration payments of 20% less than the CBHPM price is demeaning and unethical and will denounce situations that employ this practice.

16. The ABHH believes that cell therapy is a transfusion medicine procedure and together with the Brazilian Medical Association proposes that the term "cell therapy" should be officially incorporated in the name of the Association, which will now be called the "Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular".

17. The ABHH will draw up a pricelist of items in-

Coordinators

Cármino Antônio de Souza

Dante Mário Langhi Jr

Dimas Tadeu Covas

João Carlos Pina Saraiva

José Orlando Bordin

Secretaries

Antônio Fabron Jr

José Francisco Comenalli Marques Júnior

José Roberto Luzzi

Rapporteurs

Alfredo Mendrone

Eugenia Amorim Ubiali

João Pedro Marques Pereira

José Mauro Kutner

Luiz Amorim

Marília Rugani

Participants

Acacira Oliveira Bezerra Araújo

Adriana Parodi

Adriano Pereira

Adrieli de Souza Loureiro

Alessandra Quinto Bentes

Alessandra Takatu Vacarini

Alexandre Pereira

Alien dos Santos Borgo

Aline de Freitas Pereira

Aline Sampaio Fernandes

Álvaro Augusto D' Alincourt

Alvaro Augusto Passos

Amauri Antiquera Leite

Amile Martins Massucato

Ana Cynira Franco Marret

Ana Lucia Cornacchione

Ana Lúcia Girello

Ana Maria Zimmermann

Ana Orlando

Ana Suely Leite Saraiva

Andre de Macedo

André Malzoni Langhi

André Netel de Mello

Andre Norio Yamada

Andrea Carla Caffaro Copello

Andrea Frenk

Angela Maria de Melo Ferreira

Anna Bárbara de Freitas Carneiro Proietti

Antônio César Teixeira

Antonio Condino Neto

Antonio Gomes Pinto Ferreira

Audrey Akiko Hirano

Auristela Maciel Lins

Barbara de Jesus Simões

Beatriz Helena Cermaria Soares da Silva

Beatriz Tavares Costa Carvalho

Bruna Pessoa Cruz

Carla Luana Dinardo

Carlos Alberto de Macedo

Carlos Alexandre Monteiro Mesiano

Carlos Gama Sauaia

Carlos Henrique Maciel

César Gustavo Leal Galvão

Cinthya Pereira Leite Costa de Araújo

Clarisse Lopes de Castro Lobo

Claudia Cristina Naufel Terzian

Claudia Regina Abreu Silva

Cláudia Regina de Araújo Monteiro

Claudio Carneiro Borba

Claudio Marcelo Tavares Pessoa de

Melo

Claudio Siqueira

Clever Rodolfo Carvalho Vasconcelos

Cristina Pontes Langhi

Daniel Teles Galdiano

Daniela Calminatti

Daniela Jinzenji

Danila Augusta Accioly Varella Barca

Dario Garcia Adomaitis

Doralice Marvulle Tan

Edilene Cristina Sampaio R. Fernandes

Eduardo Takatu

Edvis Santos Soares Serafim

Elaine Veloso Rocha Urias

Elizabeth Angélica Leme Martins

Ellen Cristina Barros Lima de Souza

Bastos

Emanuel Borges Vitor Anjos

Fabiana Chagas Camargos Piassi

Fernanda Horn Razouk

Fernando Ghilardi

Flavia Gonzalez da Costa

Fortunée Meyohas

Francisco Guilherme Fujita Neto

Francisco Ludovico de Almeida Filho

Frederico Carbone Filho

Gabriel Alves dos Santos

Gabriela Macedo de Freitas Oliveira

Geny Aparecida de Oliveira Barna

Geraldo Sant´Ana da Cunha Junior

Gláucia Costa Esmanhotto

Glauco Plens

Gleice Fernandes

Helder Texeira Melo

Hélio Moraes de Souza

Iara de Jesus Ferreira Motta

Iracema Marques Vieira Hirtsch

Jane Terezinha Martins

Jefferson Cardoso

Joana Darc S. Ramos

João Carlos Pina Faria

João Paulo Baccara Araujo

Joel da Cunha

Joice Aragão de Jesus

Jorge Luiz de Aquino

José Antomio Rosa

José Eduardo Levi

José Guilherme Pereira de Souza

José Lindemberg da Costa Lima

José Mauro Zarnini

Juarez Pappiani

Juliane de Campos Inácio

Leandra C. N. Silva

Leandro Celso Grilo

Leila Manfredini Feitosa

Leila Maria Magalhães Pessoa de

Melo

Leila Minari

Leonardo Antunes Amorim

Levy S. Rocha Pires

Lucas de Menezes dos Santos

Luciana Campos C. Machado de

Souza

Lucimara Aguiar

Luiza Vasconcellos Lang

Lydia Márcia de Melo Franca

Manuela Zubaran Santos

Marcel Inada

Marcelo Addas Carvalho

Marcelo de Carvalho Braga

Marcelo Tha Aciioly Veiga

Marcia B. de Carvalho Polite

Marcia Cristina Zago Novaretti

Marcia Otta

Márcia Vaz Moço

Márcia Villa Nova

Maria Angelica de Camargo Soares

Maria Aparecida E. Felicetti

Maria Cristina Albe Olivato

Maria Cristina Balestrin

Maria de Fátima Alves Fernandes

Maria de Fatima Pombo Montoril

Maria do Rosário Leal Galvão

Maria Esther Duarte

Maria José Furquim

Maria Odila Jacob de Assis Moura

Mariana Sartori Magnoni

Mariangela Moschen

Mariza Saito

Marta Auxiliadora Ferreira Reis

Mauro Avanzi

Maza Alves Jacob

Merula Steagall

Moema de Oliveira Pessôa dos Santos

Monica Nascimento dos Reis

Mônica Torres Rifeiro

Nanci Alves Salles

Nixon Ramos da Silva

Noemi Élidi Martins

Olga Maria diniz Pereira

Osnei Okumoto

Osvaldo Antonio Donnini

Patricia Alvarez Baptista Brindeiro

Patricia Cressoni Sierra

Patricia da Paixão

Patricia Dadario

Paula Loureiro

Paula Renata Domeneghetti Teixeira

Paulo Silva

Paulo Tadeu Rodrigues De Almeida

Paulo Vargas

Pedro Clovis Junqueira Filho

Perla Risette Alves Lima

Poliana Cristina Carvalheiro

Priscila Ferreira Silva

Rafael Souza

Regiane de Freitas

Regina A. Pereira Moraes Dias

Regina Lucia Azevedo de Castro Mendes

Regina Rita Dutra Dantas

Ricardo Haddad

Ricardo Omoto

Ricardo S. Abreu

Rita Cavalheiro

Roberto Saturnino Chaves

Roberto Soares Schlindwein

Robson Pereira da Silva

Rodrigo Barbosa Gil

Rodrigo José Nunes Lisboa

Romeika Maria de Souza Bezerra Nelson

Romeu Ibrahim de Carvalho

Ronalda Araújo

Rosane Resende de Sousa Giuliani

Samuel Mauricio

Sérgio Augusto Pereira

Sérgio Barroca Mesiano

Sergio Domingos Vieira

Silma Maria Alves de Melo

Silvana Regina Matana

Silvano Wendel

Silvia Helena da Silva Sá Teixeira

Silvia Pereira

Silvio Ferrari Jr

Silvio Lemos Gonçalves

Simone Silveira

Simone Tcherniakovsky

Sônia Bastos

Sonia Maria Nunes de Barros

Suely Chinenn

Suely Meireles Rezende

Sylvie Boechat

Tania Maria Onzi Pietrobelli

Thiago Batista da Silva

Thiago Vilarinho Tavares

Tsutomu Oguro

Valdir Santana Lisboa

Valnei Canutti Júnior

Valnia Brandão Wanderley

Figure 1


Figure 2


Submitted: 1/10/2011

Accepted: 1/21/2011

www.rbhh.org or www.scielo.br/rbhh

  • Correspondence:

    Associação Brasileira de Hematologia e Hemoterapia
    Rua da Assembléia, 10 Gr. 1407 - Centro
    Rio de Janeiro (RJ), Brazil
  • Publication Dates

    • Publication in this collection
      05 May 2011
    • Date of issue
      Feb 2011
    Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular R. Dr. Diogo de Faria, 775 cj 114, 04037-002 São Paulo/SP/Brasil, Tel. (55 11) 2369-7767/2338-6764 - São Paulo - SP - Brazil
    E-mail: secretaria@rbhh.org